SCHEMBL15532243

SCHEMBL15532243

CN(C)C=C(C(=O)O)n1ccnn1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6114340 0.82 LMNA (0.31) LMNA
SCHEMBL6114336 0.82 LMNA (0.31) LMNA
SCHEMBL15532376 0.82 LMNA (0.31) LMNA
SCHEMBL4804379 0.79 CYP2C9 (0.41) LMNA
SCHEMBL4971138 0.70 P2RX4 (0.35)
SCHEMBL15545826 0.69
SCHEMBL15542456 0.69
SCHEMBL27993566 0.69 CYP19A1 (0.38)
SCHEMBL876240 0.68
SCHEMBL253526 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2847183-A1 METHOD FOR THE PREPARATION OF TRIAZOLE COMPOUNDS Bayer Pharma Aktiengesellschaft (DE) 2015-03-18 EP disclosed
WO-2013167552-A1 METHOD FOR THE PREPARATION OF TRIAZOLE COMPOUNDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2013-11-14 WO disclosed